Stephen Chan

1987–2026 年に発表

132
論文数
19,358
被引用数
76
h 指数
111
i10 指数

被引用数

Stephen Chan の年別被引用数1971 年: 被引用 1 件1989 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 4 件1994 年: 被引用 2 件1995 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 8 件2000 年: 被引用 22 件2001 年: 被引用 35 件2002 年: 被引用 43 件2003 年: 被引用 43 件2004 年: 被引用 63 件2005 年: 被引用 85 件2006 年: 被引用 105 件2007 年: 被引用 131 件2008 年: 被引用 178 件2009 年: 被引用 175 件2010 年: 被引用 192 件2011 年: 被引用 146 件2012 年: 被引用 171 件2013 年: 被引用 141 件2014 年: 被引用 188 件2015 年: 被引用 161 件2016 年: 被引用 150 件2017 年: 被引用 164 件2018 年: 被引用 170 件2019 年: 被引用 457 件2020 年: 被引用 560 件2021 年: 被引用 581 件2022 年: 被引用 399 件2023 年: 被引用 328 件2024 年: 被引用 453 件2025 年: 被引用 195 件2026 年: 被引用 13 件1972〜1988 年は被引用が無いため表示していません1990 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,000 件、この内訳の 24.2%中国: 引用元論文 749 件、この内訳の 9.1%イギリス: 引用元論文 617 件、この内訳の 7.5%イタリア: 引用元論文 427 件、この内訳の 5.2%ドイツ: 引用元論文 360 件、この内訳の 4.3%フランス: 引用元論文 352 件、この内訳の 4.3%カナダ: 引用元論文 297 件、この内訳の 3.6%スペイン: 引用元論文 279 件、この内訳の 3.4%オーストラリア: 引用元論文 232 件、この内訳の 2.8%日本: 引用元論文 198 件、この内訳の 2.4%スイス: 引用元論文 188 件、この内訳の 2.3%インド: 引用元論文 184 件、この内訳の 2.2%
0%24.2%その他 28.7%

分野

  • Medicine55.4%
  • Biochemistry, Genetics and Molecular Biology25.2%
  • Computer Science4.6%
  • Environmental Science2.2%
  • Materials Science2.1%
  • Immunology and Microbiology2%
  • その他8.5%

トピック

  • HER2/EGFR in Cancer Research6.3%
  • Cancer Treatment and Pharmacology4.1%
  • Breast Cancer Treatment Studies3.7%
  • Advanced Breast Cancer Therapies3.2%
  • PI3K/AKT/mTOR signaling in cancer2.3%
  • PARP inhibition in cancer therapy2%
  • その他78.4%

共著者

全論文

検索で開く
  1. Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 389

  2. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2006 被引用: 3,461

  3. Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 262

  4. Towards Automated Annotation of Benthic Survey Images: Variability of Human Experts and Operational Modes of Automation

    著者: , , , , , , , , , , , , , , - PLoS ONE 2015 被引用: 381

  5. RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 1,061

  6. Representativeness of Eddy-Covariance flux footprints for areas surrounding AmeriFlux sites

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy J. Griffis, Manuel Helbig, David Y. Hollinger, Elyn Humphreys, Hiroki Ikawa, Hiroki Iwata, Yang Ju, John F. Knowles, Sara Knox, Hideki Kobayashi, Thomas E. Kolb, B. E. Law, Xuhui Lee, M. E. Litvak, Heping Liu, J. William Munger, Asko Noormets, Kim Novick, Steven F. Oberbauer, Walter C. Oechel, Patty Oikawa, S. A. Papuga, Elise Pendall, Prajaya Prajapati, John H. Prueger, William L. Quinton, Andrew D. Richardson, Eric S. Russell, Russell L. Scott, Gregory Starr, Ralf M. Staebler, Paul C. Stoy, Ellen Stuart‐Haëntjens, Oliver Sonnentag, Ryan C. Sullivan, Andy Suyker, Masahito Ueyama, Rodrigo Vargas, Jeffrey D. Wood, Donatella Zona - Agricultural and Forest Meteorology 2021 被引用: 504

  7. A New Deep Learning Engine for CoralNet

    著者: , , , , - IEEE/CVF International Conference on Computer Vision Workshops (ICCVW) 2021 被引用: 76

  8. Discovery and Structure–Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening

    著者: , , , , , , , - Journal of Medicinal Chemistry 2016 被引用: 146

  9. GARCH Modelling of Cryptocurrencies

    著者: , , , - Journal of risk and financial management 2017 被引用: 344

  10. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Molecular Oncology 2014 被引用: 149

  11. Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly Mousa, Javier Cortés - JAMA Oncology 2019 被引用: 90

  12. Multimodal human attention detection for reading from facial expression, eye gaze, and mouse dynamics

    著者: , , , - ACM SIGAPP Applied Computing Review 2016 被引用: 51

  13. Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer

    著者: , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2014 被引用: 210

  14. The adaptive market hypothesis in the high frequency cryptocurrency market

    著者: , , - International Review of Financial Analysis 2019 被引用: 138

  15. CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 251

  16. Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Doris Augustin, Heiko Graf, Georg Heinrich, Hendrik Kroening, Sherko Küemmel, Volkmar Müller, Friedrich Overkamp, Tjoung‐Won Park‐Simon, Marcus Schmidt, Lidia Perlova-Griff, Christopher Wolf, Marco Colleoni, Alberto Ballestrero, Antônio Bernardo, Angela Stefania Ribecco, Luca Gianni, Giuseppe Curigliano, E. Brewczynska, Jacek Jassem, Vadim Shirinkin, Alexey Manikhas, В. В. Дворниченко, Mikhail Lichinitser, Semiglazov Vf, Guzel Mukhametshina, Irina Bulavina, Enrique Espinosa Arranz, Francisco Carabantes Ocón, Guillermo López-Vivanco, Javier Salvador Bofill, Ignacio Porras Quintela, Alfonso Sánchez Muñoz, Yolanda Fernández Pérez, Javier Cassinello Espinosa, Jose Alvarez, Rodrigo Lastra del Prado, LuisLa Cruz De Merino, José Manuel Pérez García, Santos Enrech Francés, Per Edlund, Bengt Norberg, Anna-Karin Wennstig, Pehr Lind, Nik Hauser, Christoph Tausch, Celalettin Camcı, Fikret Arpacı, Hüseyin Abalı, Rüçhan Uslu, Saad Tahir, Duncan Wheatley, Stephen Chan, Peter Barrett‐Lee, Karen McAdam, Richard Simcock, Russell Burcombe, Robert H. El-Maraghi, Nadia Califaretti, Silvana Spadafora, Sandeep Sehdev, Amer Sami, Sunil Verma - Annals of Oncology 2014 被引用: 176

  17. Development of Decellularized Human Umbilical Arteries as Small-Diameter Vascular Grafts

    著者: , , , , - Tissue Engineering Part A 2009 被引用: 248

  18. Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study

    著者: , , , , , , , , , , , , - Annals of Oncology 2016 被引用: 114

  19. Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer

    著者: , , , , , , , , - Clinical Cancer Research 2013 被引用: 108

  20. A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Breast Cancer Research and Treatment 2008 被引用: 803

  21. Hippocampal sclerosis after febrile status epilepticus: The FEBSTAT study

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2013 被引用: 282

  22. AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 257

  23. MRI abnormalities following febrile status epilepticus in children

    著者: , , , , , , , , , , , , - Neurology 2012 被引用: 212

  24. Bitcoin versus high-performance technology stocks in diversifying against global stock market indices

    著者: , , - Physica A Statistical Mechanics and its Applications 2021 被引用: 32